0002115419-26-000001.txt : 20260304 0002115419-26-000001.hdr.sgml : 20260304 20260304100030 ACCESSION NUMBER: 0002115419-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260304 DATE AS OF CHANGE: 20260304 EFFECTIVENESS DATE: 20260304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Persevere Therapeutics Inc. CENTRAL INDEX KEY: 0002115419 ORGANIZATION NAME: EIN: 333427249 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-575357 FILM NUMBER: 26719213 BUSINESS ADDRESS: STREET 1: 851 DUPORTAIL ROAD, 2ND FLOOR CITY: CHESTERBROOK STATE: PA ZIP: 19087 BUSINESS PHONE: 610.780.0622 MAIL ADDRESS: STREET 1: 851 DUPORTAIL ROAD, 2ND FLOOR CITY: CHESTERBROOK STATE: PA ZIP: 19087 D 1 primary_doc.xml X0708 D LIVE 0002115419 Persevere Therapeutics Inc. 851 DUPORTAIL ROAD, 2ND FLOOR CHESTERBROOK PA PENNSYLVANIA 19087 610.780.0622 DELAWARE None None Corporation true 2025 Greg Bosch 851 DUPORTAIL ROAD, 2ND FLOOR CHESTERBROOK PA PENNSYLVANIA 19087 Executive Officer Director Other Decline to Disclose 06b false 2026-02-11 false true false 0 4999999 1574999 3425000 false 12 0 0 0 false Persevere Therapeutics Inc. Greg Bosch Greg Bosch CEO 2026-03-04